Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with OutcomeYves Allory, Francisco X. Real, Angela A.G. van Tilborg et al.|European Urology|2013Cited by 289
Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder CancerEmil Christensen, Lars Dyrskjøt, Karin Birkenkamp‐Demtröder et al.|European Urology|2017Cited by 197
Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for CystoscopyKim E.M. van Kessel, Ellen C. Zwarthoff, Willemien Beukers et al.|The Journal of Urology|2016Cited by 154
Microsatellite Analysis of Voided-Urine Samples for Surveillance of Low-Grade Non-Muscle-Invasive Urothelial Carcinoma: Feasibility and Clinical Utility in a Prospective Multicenter Study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer Trial [CEFUB])Madelon N.M. van der Aa, Theodorus van der Kwast, Ellen C. Zwarthoff et al.|European Urology|2008Cited by 96
Molecular Markers Increase Precision of the European Association of Urology Non–Muscle-Invasive Bladder Cancer Progression Risk GroupsKim E.M. van Kessel, Ellen C. Zwarthoff, Kirstin A. van der Keur et al.|Clinical Cancer Research|2018Cited by 92